Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Blood
|
May 21, 2011
Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL
Alan M Hanash, Lucy W Kappel, Nury L Yim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2025
Reduced monocytic IL10 expression in PD1 inhibitor-treated patients is a harbinger of severe immune-related adverse events
Stanislav Rosnev, Baldur Sterner, Phillip Schiele, et al.
Blood
|
June 1, 2010
Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo
Il-Kang Na, John C Markley, Jennifer J Tsai, et al.
International Journal of Cancer
|
July 23, 2024
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth
Kamila Pulawska-Moon, Donata Ponikwicka-Tyszko, Weronika Lebiedzinska, et al.
Blood
|
January 6, 2026
Clonal Hematopoiesis and Lymphoma-Associated Mutations in Hematopoietic Progenitors in B-Cell Non-Hodgkin Lymphoma
Laura Wiegand, Patricia Silva, Daniel Noerenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2023
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212)
Arndt Stahler, Beeke Hoppe, Il-Kang Na, et al.
Nature Immunology
|
April 11, 2018
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
Quirin Hammer, Timo Rückert, Eva Maria Borst, et al.
Journal of the National Cancer Institute
|
May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth
Olaf Penack, Erik Henke, David Suh, et al.
Blood
|
November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
Robert R Jenq, Christopher G King, Christine Volk, et al.
The Journal of Clinical Investigation
|
December 4, 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease
Il-Kang Na, Sydney X Lu, Nury L Yim, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Blood
|
May 21, 2011
Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL
Alan M Hanash, Lucy W Kappel, Nury L Yim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2025
Reduced monocytic IL10 expression in PD1 inhibitor-treated patients is a harbinger of severe immune-related adverse events
Stanislav Rosnev, Baldur Sterner, Phillip Schiele, et al.
Blood
|
June 1, 2010
Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo
Il-Kang Na, John C Markley, Jennifer J Tsai, et al.
International Journal of Cancer
|
July 23, 2024
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth
Kamila Pulawska-Moon, Donata Ponikwicka-Tyszko, Weronika Lebiedzinska, et al.
Blood
|
January 6, 2026
Clonal Hematopoiesis and Lymphoma-Associated Mutations in Hematopoietic Progenitors in B-Cell Non-Hodgkin Lymphoma
Laura Wiegand, Patricia Silva, Daniel Noerenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2023
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212)
Arndt Stahler, Beeke Hoppe, Il-Kang Na, et al.
Nature Immunology
|
April 11, 2018
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
Quirin Hammer, Timo Rückert, Eva Maria Borst, et al.
Journal of the National Cancer Institute
|
May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth
Olaf Penack, Erik Henke, David Suh, et al.
Blood
|
November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
Robert R Jenq, Christopher G King, Christine Volk, et al.
The Journal of Clinical Investigation
|
December 4, 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease
Il-Kang Na, Sydney X Lu, Nury L Yim, et al.
Page
of 9